Search for: "In re: S.D. & S.D"
Results 141 - 160
of 833
Sort by Relevance
|
Sort by Date
5 Jun 2020, 11:18 am
Narang & Stephan R. [read post]
2 Jun 2020, 12:54 am
I. du Pont de Nemours & Co. [read post]
13 May 2020, 2:03 am
Supp. 2d 736, 742 (S.D. [read post]
11 May 2020, 1:09 am
In my last post,[1] I praised Lee Mickus’s recent policy paper on amending Rule 702 for its persuasive force on the need for an amendment, as well as a source for helping lawyers anticipate common judicial dodges to a faithful application of the rule.[2] There are multiple dodges used by judicial dodgers, and it behooves litigants to recognize and anticipate them. [read post]
4 May 2020, 7:05 am
Petrotech Res. [read post]
29 Apr 2020, 8:36 pm
Johnson & Johnson Consumer, Inc., et al., No. 19-cv-1345 (S.D. [read post]
20 Apr 2020, 5:01 am
Adverse event reporting is a recognized, important component of pharmacovigilence. [read post]
11 Apr 2020, 5:16 am
Legg & A.J. [read post]
30 Mar 2020, 4:59 am
Heritage Bank (In re Hart), 564 F. [read post]
19 Mar 2020, 10:35 am
§ 157(b)(2)(A), (M), & (O). [read post]
11 Mar 2020, 1:39 pm
S.D. [read post]
11 Mar 2020, 1:39 pm
S.D. [read post]
CAFC affirms inequitable conduct ruling in GS Cleantech; bad behavior of patent attorneys implicated
3 Mar 2020, 8:02 am
Corrected Memorandum Opinion & Order afterBench Trial, In re: Method of Processing Ethanol Byproducts & Related Subsystems (’858) Patent Litig., No. 1:10-ml-02181-LJM-DML (S.D. [read post]
22 Feb 2020, 6:11 am
§ 1334(b) and the Standing Order of Reference, Amended General Order No. 05‐02 (S.D. [read post]
22 Feb 2020, 4:12 am
Supp. 2d 765, 770 (S.D. [read post]
18 Feb 2020, 9:20 am
S.D. [read post]
18 Feb 2020, 9:19 am
S.D. [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
8 Jan 2020, 12:13 pm
In Re: Qualcomm litigation Case No. 3:17cv0108-GPC-MDD (S.D. [read post]
6 Jan 2020, 7:53 am
Edwards, 2018 WL 456320 (S.D. [read post]
